Not just Colombia: Novartis has charged more for some drugs in Mexico, too

7006_cut-636x617STAT News
 Veronika Wirtz, School of Public Health

As Novartis grapples with controversy over its pricing in Colombia, internal company data show the drug maker has also charged higher prices for some widely used medicines in other Latin American countries — notably, Mexico — than in many wealthy nations…

Expert quote:

“This raises questions as to why Novartis is able to charge such prices in countries with lower incomes,” said Veronika Wirtz, an associate professor of global health at Boston University.”

View full article